The free radical theory of disease (caused by oxygen free radicals)
provides one scientific explanation for the many observed benefits
following chelation therapy. Many scientific studies published in peer
reviewed medical journals provide solid clinical evidence for benefit.
This non-invasive therapy is very much safer and far less expensive
than surgery or angioplasty.
Chelation therapy is a safe and effective alternative to bypass
surgery, angioplasty and stents. Hardening of the arteries need not
lead to coronary bypass surgery, heart attack, amputation, stroke, or
senility. There is new hope for victims of these and other related
diseases. Despite what you may have heard from other sources, EDTA
chelation therapy, administered by a properly trained practitioner, in
conjunction with a healthy lifestyle, prudent diet, and nutritional
supplements, is an option to be seriously considered by persons
suffering from coronary artery disease, cerebral vascular disease,
brain disorders resulting from circulatory disturbances, generalized
hardening of the arteries (atherosclerosis, also called
arteriosclerosis) and related ailments which can lead to stroke, heart
attack, senility, gangrene, and accelerated physical decline.
Clinical benefits from chelation therapy vary with the total number of
treatments received and with severity of the condition being treated.
On average, 85 percent of chelation patients have improved very
significantly. More than 90 percent of patients receiving 30 or more
chelation infusions have benefited enough to be grateful for this
therapy—even more so when they also followed a healthy lifestyle,
avoiding the use of tobacco. Symptoms improve, blood flow to diseased
organs increases, need for medication often decreases and, most
importantly, the quality of life becomes more productive and
When patients first hear about or consider EDTA chelation therapy,
they normally have lots of questions. Undoubtedly you do, too. Here
are the answers to those most commonly asked questions, explained in
WHAT IS "CHELATION"?
Chelation (pronounced KEY-LAY-SHUN) is the process by which a metal or
mineral (such as calcium, lead, cadmium, iron, arsenic, aluminum,
etc.) is bonded to another substance―in this case EDTA, an amino acid.
It is a natural process, basic to life itself. Chelation is one
mechanism by which such common substances as aspirin, antibiotics,
vitamins, minerals and trace elements work in the body. Hemoglobin,
the red pigment in blood which carries oxygen, is a chelate of iron.
WHAT IS CHELATION AS A MEDICAL THERAPY?
Chelation is a treatment by which a small amino acid called ethylene
diamine tetraacetic acid (commonly abbreviated EDTA) is slowly
administered to a patient intravenously over several hours, prescribed
by and under the supervision of a licensed health care practitioner.
The IV fluid containing EDTA is infused through a small needle placed
in the vein of a patient’s arm. The EDTA infusion bonds with
unbalanced metals in the body and quickly redistributes them in a
healthy way, or carries them away in the urine. Abnormally situated
nutritional metals, such as iron, along with toxic elements such as
lead, mercury and aluminum are easily removed by EDTA chelation
therapy. Normally present minerals and trace elements which are
essential for health are more tightly bound within the body and can be
maintained with a properly balanced nutritional supplement.
IS IT DONE JUST ONCE?
On the contrary, chelation therapy usually consists of anywhere from
20 to 50 separate infusions, depending on each patient’s individual
health status. Thirty treatments is the average number required for
optimum benefit in patients with symptoms of arterial blockage. Some
patients eventually receive more than 100 chelation therapy infusions
over several years. Other healthier patients receive only 20 infusions
as part of a preventive program. Each chelation treatment takes three
hours or longer and patients cannot receive more than one treatment
each day. It is the total number of treatments that determine results,
not the schedule or frequency. Some patients receive treatments daily
and others come weekly or at at variable intervals as convenience and
their schedule dictates. Over a period of time, these injections halt
the progress of the free radical disease. Free radicals underlie the
development of atherosclerosis and many other degenerative diseases of
aging. Reduction of damaging free radicals it believed to allow
diseased arteries to heal, restoring blood flow. With time chelation
therapy brings profound improvement to many essential metabolic and
physiologic functions in the body. The body’s regulation of calcium
and cholesterol is restored by normalizing the internal chemistry of
cells. Chelation has many favorable actions on the body.
Chelation therapy benefits the flow of blood through every vessel in
the body, from the largest to the tiniest capillaries and arterioles,
most of which are far too small for surgical treatment or are deep
within the brain where they cannot be safely reached by surgery. In
many patients, the smaller blood vessels are the most severely
diseased, especially in the presence of diabetes. The benefits of
chelation occur simultaneously from the top of the head to the bottom
of the feet, not just in short segments of a few large arteries which
can be bypassed by surgical treatment.
DO I HAVE TO GO TO A HOSPITAL TO BE CHELATED?
No, chelation therapy is an out-patient treatment available in a
physician’s office or clinic.
DOES IT HURT? WHAT DOES IT FEEL LIKE TO BE CHELATED?
Being "chelated" is quite a different experience from other medical
treatments. There is no pain, and in most cases, very little
discomfort. Patients are seated in reclining chairs and can read, nap,
watch TV, do needlework, or chat with other patients while the fluid
containing the EDTA flows into their veins. If necessary, patients can
walk around. They can visit the restroom, eat and drink as they
desire, or make telephone calls, being careful not to dislodge the
needle attached to the intravenous infusion they carry with them. Some
patients even run their businesses by telephone or computer while
receiving chelation therapy.
ARE THERE RISKS OR UNPLEASANT SIDE
EDTA chelation therapy is relatively non-toxic and risk-free,
especially when compared with other treatments. Patients routinely
drive themselves home after chelation treatment with no difficulty.
The risk of significant side effects, when properly administered, is
less than 1 in 10,000 patients treated. By comparison, the overall
death rate as a direct result of bypass surgery is approximately 3 out
of every 100 patients, varying with the hospital and the operating
team. The incidence of other serious complications following surgery
is much higher, approaching 25%, including heart attacks, strokes,
blood clots, mental impairment, infection, and prolonged pain.
Chelation therapy is at least 300 times safer than bypass surgery.
Occasionally, patients may suffer minor discomfort at the site where
the needle enters the vein. Some temporarily experience mild nausea,
dizziness, or headache as an immediate aftermath of treatment, but in
the vast majority of cases, these minor symptoms are easily relieved.
When properly administered by a trained health care practitioner
expert in this type of therapy, chelation is safer than many other
prescription medicines. Statistically speaking, the treatment itself
is safer than the drive in an automobile to the doctors office.
If EDTA chelation therapy is given too rapidly or in too large a dose
it may cause harmful side effects, just as an overdose of any other
medicine can be dangerous. Reports of serious and even rare fatal
complications many years ago stemmed from excessive doses of EDTA,
administered too rapidly and without proper laboratory monitoring. If
you choose a provider with proper training and experience, who is an
expert in the use of EDTA, the risk of chelation therapy will be kept
to a very low level.
While it has been stated by critics that EDTA chelation therapy is
damaging to the kidneys, the newest research (consisting of kidney
function tests done on hundreds of consecutive chelation patients,
before and after treatment with EDTA for chronic degenerative
diseases) indicates the reverse is true. There is, on the average,
significant improvement in kidney function following chelation
therapy. An occasional patient may be unduly sensitive, however, and
practitioners expert in chelation monitor kidney function with
laboratory testing to avoid overloading the kidneys. Chelation
treatments must be given more slowly and less frequently if kidney
function is not normal. Patients with some types of severe kidney
problems should not receive EDTA chelation therapy.
WHAT TYPES OF EXAMINATIONS AND TESTING MUST BE DONE PRIOR TO
BEGINNING CHELATION THERAPY?
Prior to commencing a course of chelation therapy a complete medical
history is obtained. Diet is analyzed for nutritional adequacy and
balance. Copies of pertinent medical records and summaries of hospital
admissions may be sent for. A thorough head-to-toe, hands-on physical
examination will be performed. A complete list of current medications
will be recorded, including the time and strength of each dose.
Special note will be made of any allergies.
Blood and urine specimens will be obtained in a battery of tests to
insure that no conditions exist which should be treated differently or
might be worsened by chelation therapy. Kidney function will be
carefully assessed. An electrocardiogram is usually obtained.
Noninvasive tests will be performed, as medically indicated, to
determine the status of arterial blood flow prior to therapy. A
consultation with other medical specialists may be requested.
IS CHELATION THERAPY NEW?
Not at all. Chelation's earliest application with humans was before
World War II when the British used another chelating agent, British
Anti-Lewesite (BAL), as a poison gas antidote. BAL is related to
chelators still used today in medicine.
EDTA was first introduced into medicine in the United States in 1948
as a treatment for industrial workers suffering from lead poisoning in
a battery factory. Shortly thereafter, the U.S. Navy advocated
chelation therapy for sailors who had absorbed lead while painting
government ships and dock facilities. In the years since, chelation
therapy has remained the undisputed treatment-of-choice for lead
poisoning, even in children with toxic accumulations of lead in their
bodies as a result of eating leaded paint from toys, cribs or walls.
In the early 1950’s it was speculated that EDTA chelation therapy
might help the accumulations of calcium associated with hardening of
the arteries. Experiments were performed and victims of
atherosclerosis experienced health improvements following chelation—diminished
angina, better memory, sight, hearing and increased vigor. A number of
practitioners then began to routinely treat individuals suffering from
occlusive vascular conditions with chelation therapy. Consistent
improvements were reported for most patients.
Published articles describing successful treatment of atherosclerosis
with EDTA chelation therapy first appeared in medical journals in
1955. Dozens of favorable articles have been published since then. No
unsuccessful results have ever been reported (with the exception of
several recent studies with very flawed data deceptively presented by
bypass surgeons, in a seeming attempt to discredit this competing
therapy). There have also been a number of editorial comments of a
critical nature made by physicians with vested interests in vascular
surgery and related procedures.
From 1964 on, despite continued documentation of its benefits and the
development of safer treatment methods, the use of chelation for the
treatment of arterial disease has been the subject of controversy.
IS IT LEGAL?
Absolutely. There is no legal prohibition against a licensed medical
doctor using chelation therapy for whatever conditions he or she deems
it to be in the best interests of their patients, even though the drug
involved, EDTA, does not yet have atherosclerosis listed as an
indication on the FDA-approved package insert. Contrary to popular
belief, the FDA does not regulate the practice of medicine, but merely
approves marketing, labeling and advertising claims for drugs and
devices sold in interstate commerce.
It costs many millions of dollars to perform the required research and
to provide the FDA with documentation for a new drug claim, or even to
add a new use to marketing brochures of a long established medicine
like EDTA. Physicians routinely prescribe medicines for conditions not
included on FDA approved advertising and marketing literature.
The American College for Advancement in Medicine conducts educational
courses in the proper and safe use of intravenous EDTA chelation twice
yearly. They also publish a
Protocol which contains professionally recognized standards of
medical practice for chelation therapy.
On the question of
legality, courts have expressed the opinion that a practitioner
who withholds information about the availability of other treatment
choices, such as chelation therapy, prior to performing vascular
surgery (along with all other treatment modalities) is in violation of
the doctrine of informed consent. Withholding information about a form
of treatment may be tantamount to medical malpractice, if as a result,
a patient is deprived of possible benefit. Thus, it is the doctors who
refuse to recognize and inform their patients about chelation who are
risking legal liability—not those chelating practitioners informed
enough to resist peer pressure and provide an innovative treatment
which they feel to be the safest, the most effective and the least
expensive for many of their patients.
WHAT PROOF DO YOU HAVE THAT IT WORKS?
Practitioners with extensive experience in the use of chelation
therapy observe dramatic improvement in the vast majority of their
patients. They see angina routinely relieved; patients who suffered
searing chest and leg pain when walking only a short distance are
frequently able to return to normal, productive living after
undergoing chelation therapy. Far more dramatic, but equally common,
is seeing diabetic ulcers and gangrenous feet clear up in a matter of
weeks. Individuals who have been told that their limbs would need to
be amputated because of gangrene are thrilled to watch their feet heal
with chelation therapy, although some areas of dead tissue may still
have to be trimmed away surgically.
The approximately 1,500 American practitioners practicing chelation
therapy, plus hundreds of others in foreign countries, have countless
case histories to prove they are able to reverse serious cases of
arterial disease. Men and women often arrive at doctors’ offices near
death with diseases caused by blocked arteries. Weeks or months later,
they’re remarkably improved. There is a wealth of evidence from
clinical experience that symptoms of reduced blood flow improve in up
to 85 percent of patients treated. More than a million patients have
thus far received chelation therapy, almost as many as have undergone
trials of chelation therapy have been positive. There are no
negative data, although a few report had a deceptively negative spin
on positive data. In addition, several
studies have been published with results of before-and-after
diagnostic tests using radio-isotopes and ultra sound which prove
statistically that blood flow increases following chelation therapy.
Even without blood-flow studies, if leg pain on walking is relieved,
if angina becomes less bothersome, and if physical endurance and
mental acuity improve, such benefits would be quite enough to justify
EDTA chelation therapy. Improved quality of life and relief of
symptoms are the most important benefits of chelation therapy.
WHAT DOES IT COST?
A course of chelation therapy for a patient with advanced hardening of
the arteries generally requires from six weeks to six months and costs
up to $4,000 or more for 30 treatments. This is considerable less than
bypass surgery which is normally well over $40,000. A person can
expect to pay approximately $115 per treatment, including the
associated kidney tests. Each chelation treatment takes 3 to 4 hours
to complete. Although some clinics give faster treatments, a faster
dose of EDTA must be reduced for safety with resulting reduced
benefit. Some use rapid infusions of calcium EDTA, which risks cause
kidney damage and has never been shown in research studies to provide
the same benefit as disodium EDTA.
WHAT ABOUT BYPASS SURGERY?
Coronary artery bypass surgery, the popularly-prescribed procedure in
which blocked portions of major coronary arteries of the heart are
bypassed with grafts from a patient’s leg veins, has never been proven
by properly controlled studies to offer much or an advantage over
non-surgical treatments, other that relief of pain in a minority of
patients who cannot be controlled with medicine. It has even been
suggested that the relief of pain following surgery might result from
the cutting of nerve fibers which carry pain impulses from the heart
and which also stimulate spasm of coronary arteries. It is not
possible to perform bypass surgery without interrupting those nerves.
Arteriograms which are done to x-ray and visualize the arteries prior
to surgery utilize a chemical dye which can cause arterial spasm. It
is difficult to determine on the x-rays how much arterial blockage is
permanent and how much is reversible spasm. It is common practice
during angiograms to inject medication that amplifies the effects of
diseased coronary arteries.
Indeed, the most recent research suggests that many of the more than
200,000 bypasses performed each year for the relief of pain and other
symptoms brought on by clogged or blocked arteries are not necessary.
A good case against rushing into bypass surgery is made by the
findings of a ten-year, $24-million study conducted by the National
Institutes of Health (NIH) which compared post-operative survival
rates of "bypassed" patients with a matched group of equally diseased
patients treated non-surgically.
uncovered no advantage for the majority of patients who had been
operated upon, compared with those receiving non-surgical therapy.
It is important to note that the non-surgical therapy reported in that
study did not include either chelation therapy or the newer calcium
blocker drugs, and that only half of the patients received beta
blocker drugs. Although studies have been reported to show that
patients with left main coronary artery blockage live slightly longer
after surgery, the studies were done before calcium blockers and newer
beta blockers were available. Those medicines have been scientifically
proven to protect against heart attack. Surgery might have come out a
clear second best if all presently available non-surgical treatments,
including chelation, had been compared to bypass.
Having surgery didn’t improve the chances for most patients to live
longer, live healthier, live better, or enjoy life more , when the
results were statistically analyzed. The incidence of heart attacks
(myocardial infarction) and both employment and recreational status
were the same when comparing a large group of patients treated
surgically with those treated non-surgically, even without using
chelation therapy for the non-surgical treatment group.
Most importantly, cardiovascular surgery does nothing to arrest or
reverse the underlying disease, which exists in varying degrees
throughout the body. It is at best a piecemeal "cure" for a
system-wide problem. Bypassing a tiny portion of the body’s blood
vessels can have little lasting benefit when the same degenerating
condition which caused the most extreme blockage at one or two sites
must of necessity be taking place everywhere, throughout the
One thing the general public is not fully aware of is that many people
who have one bypass operation later need a second bypass. Sometimes
the blood vessels that weren’t bypassed become clogged and also need
bypassing; sometimes the transplanted vessels used in the first graft
become filled with new plaque; not uncommonly, the transplants
malfunction or turn out to be too small for the job. As a matter of
fact, studies have shown that by ten years after surgery, grafted
vessels had closed in 40 percent of patients, and in the remaining 60
percent, half developed further coronary narrowing. Once you’ve had a
bypass, your chances of being referred for another go up about five
percent a year. After five years, some surgical specialists estimate,
your need for a second operation could be as high as 30 to 40 percent.
And some patients go on to even a third operation or more. And
approximately 2 to 3 out of every 100 patients undergoing bypass
surgery die as a result of the procedure—even more if they are
severely ill at the time of surgery. A much larger percentage suffer
serious complications, even after they survive the surgery. Those
percentages are similar for balloon angioplasty—with or without stents.
Chelation patients are frequently able to return to work and to resume
their sports and other activities, without the need to undergo
surgery. If they stay on a proper diet, exercise within limits of
tolerance, continue to take the prescribed program of nutritional
supplements, and receive periodic maintenance chelation treatments
(every one to two months, depending on the severity of the underlying
medical diagnosis) they can usually go many years without suffering
further heart attacks, strokes, senility or gangrenous extremities.
If you have been told, like most people eager for additional
information about chelation therapy, that you have advanced arterial
disease, you may have been advised to have vascular surgery or balloon
angioplasty. If so, it is essential for you to understand the nature
of your disease and all possible treatment choices, before you can
make an intelligent decision concerning the various options. Even if
chelation therapy and other non-surgical therapies should fail, bypass
still remains a choice. Although bypass can relieve symptoms, as a
last resort, surgery does not prevent heart attacks or prolong live in
the vast majority of patients operated.
WHY CAN’T CHELATION BE TAKEN BY MOUTH
IN PILL FORM INSTEAD OF BY INTRAVENOUS INJECTION?
Chelation therapy is gaining recognition so rapidly that there is
growing interest in developing an oral chelator that will produce
benefits similar to intravenous EDTA chelation therapy. Many
nutritional substances administered by mouth are known to have
chelating properties but none have the spectrum of activity of
intravenous EDTA. Many nutrients such as vitamin C and the amino acids
cysteine and aspartic acid have the ability to weakly chelate metals.
They also protect against free radical damage in other ways, as
Claims are being increasingly made for the use of nutritional
supplements containing weak chelators in patients with
atherosclerosis. There is nothing new about these products which are
mostly vitamins and minerals being aggressively marketed with glowing
testimonials and deceptive marketing techniques. Benefit from products
taken by mouth has never even come close to the much more dramatic
results seen with intravenous EDTA.
nutritional supplements which contain EDTA have been alleged to be
effective as oral chelation therapy. The problem is that only 5
percent or less of EDTA is absorbed by mouth. The same tiny percentage
applies to rectal suppositories. The remainder passes out in the
stool. And, it must be taken every day by mouth to absorb even a small
amount. When taken on a daily basis, oral EDTA binds essential
nutrients in the digestive tract and blocks their absorption, causing
deficiencies. When given intravenously, EDTA is 100 percent absorbed
very rapidly and eliminated in the urine within a few hours.
Intravenous EDTA is given on only 20 to 30 days in any one year and
does not lead to deficiencies of nutritional minerals. Nutritional
supplementation on a daily basis more than compensates for any loses
caused by the intravenous EDTA chelation therapy.
IS IT TRUE THAT CHELATION THERAPY COMBATS ATHEROSCLEROSIS BY
ACTING LIKE A LIQUID PLUMBER—BY LEACHING CALCIUM
OUT OF ATHEROSCLEROTIC PLAQUE?
No! Before recent medical breakthroughs in the area of free radical
pathology, it was hypothesized that EDTA chelation therapy had its
major beneficial effect on calcium metabolism—that it stripped away
the excess calcium from the plaque, restoring arteries to their
pliable precalcified state. This frequently offered explanation—the
so-called "roto-rooter" concept—is not the real reason, as previously
postulated, that chelation therapy produces its major health benefits.
The fact that EDTA does reduce some calcium from plaque is felt to be
only one of its benefits, an probably not the mos important.
Nonetheless, calcium does play a role and is one reason why the use of
EDTA is not recommended. Calcium EDTA has no beneficial effect on
calcium deposits in the body.
Most importantly, EDTA has an affinity for the transition metal, iron,
a free radical catalyst in excess, and for the toxic metals, lead,
mercury, cadmium, nickel, and aluminum. Free radical pathology, it is
now believed, is an important underlying process triggering the
development of many age-related ailments, including cancer, senility
and arthritis, as well as atherosclerosis. Thus, EDTA’s most important
benefit seems to be that it
reduces the ongoing production of free radicals within the body by
removing accumulations of metallic catalysts and toxins which
accumulate at abnormal sites in the body as a person grows older and
which speed the aging process. There are
theories of mechanism of action and we still do not know which is
most important. Recent research even points to
rebalancing toxic accumulations of essential elements such a zinc,
chromium and cobalt.
For readers with a decided interest in the scientific technicalities
you can refer to the article entitled
Scientific Rational for EDTA Chelation Therapy: Mechanism of
Action by Elmer M. Cranton, M.D. and James P. Frackelton, M.D.
For a fuller explanation of the many issues involved, you will enjoy
reading BYPASSING BYPASS
SURGERY, a full-length book by Elmer M. Cranton, M.D., which is
written in popular form for the general public. The article on the
scientific rationale and mechanism of action, mentioned in the last
paragraph, is also contained as a chapter in that book under the
heading, "Take This to Your Doctor."
WHAT OTHER DISEASES MIGHT BE
BENEFITED BY CHELATION?
Because the very aging process itself correlates with ongoing free
radical damage, it is no surprise that a large variety of symptoms
have been reported to improve following chelation therapy, even
symptoms not directly caused by circulatory disease. While there is no
scientific evidence that chelation is a cure for these diseases,
symptoms of arthritis, Alzheimer’s, Parkinson’s , psoriasis, high
blood pressure, and scleroderma have all been reported to improve with
chelation therapy. In fact, there is no better treatment for
scleroderma. Vision has been improved in macular degeneration.
Patients generally feel younger and more energetic following therapy,
even when taken for purely preventive reasons. In fact, chelation
therapy is more desirable for prevention that it is for established
disease. Preventive medicine is always preferable to late stage crisis
A recently published article from the University of Zurich in
Switzerland reported an 18-year follow-up of a group of 56 chelation
therapy patients. When comparing the death rate from cancer with that
of a control group of patients who did not receive chelation therapy,
the authors found that patients who received EDTA chelation therapy
had a 90%
reduction of cancer deaths. Epidemiologists from the University of
Zurich reviewed the data and found no fault with the reported facts or
There is no evidence that chelation therapy is of benefit in the
treatment of advanced cancer, once the diagnosis is made, but there is
a large body of scientific research indicating that free radical
damage to DNA is an important factor at the onset of most cancer.
Chelation therapy blocks damaging free radicals.
therapy help with heart valve problems such as
aortic stenosis or mitral regurgitation?
EDTA chelation will not have much effect on diseased heart valves as
such. However, chelation has been shown to improve the efficiency of
cardiac function and relieve symptoms and reduce probability of heart
attack and other complications. If surgical replacement of the valve
becomes necessary, prior chelation therapy should speed recovery and
reduce the probability of serious surgical complications such as
stroke or myocardial infarction ( heart attack).
WHY HAVEN’T I HEARD OF
If EDTA chelation therapy is safe and effective as indicated by many
published studies, and by the experience of hundreds of doctors, why
haven’t you heard more about it? That is a good question!
Until quite recently, relatively few patients have been informed that
this therapy is available. Many heart specialists may not have even
heard of the treatment and would be reluctant to prescribe it if they
had. The American Medical Association has not yet approved chelation
therapy for atherosclerosis, although it does endorse its use in the
treatment of lead poisoning. Many insurance companies will not
compensate policy holders for chelation therapy unless it is given for
proven lead poisoning of a serious degree. If chelation therapy is
given for atherosclerosis, it is often labeled "experimental" or "not
necessary " or "not customary" by medical insurance companies and
payment is denied. They deny payment to patients for chelation therapy
even though they do pay for bypass surgery, and even though chelation
might have saved them tens of thousands of dollars. Like many other
aspects of our lives, a considerable amount of politics seems to be
involved—in this case, medical politics.
Politically powerful traditional medical groups and manufacturers of
cardiovascular drugs have consistently suppressed knowledge of
chelation therapy, perhaps because of a large vested interest in
competing coronary related health care. The cost of all medical care
for victims of heart disease in the United States, including coronary
bypass surgery and prescription drugs, exceeds $50 billion per year.
Obviously, many hospitals, physicians, and pharmaceutical companies
would experience a decline in need for their services if chelation
therapy were to become universally popular.
Physicians who remain skeptical about chelation therapy are those who
have never used it. They are either completely uninformed about the
research that has been done to document the safety and effectiveness
of chelation therapy, or they are committed by training or source of
income to other therapeutic procedures, such as vascular surgery and
related procedures. Many physicians have merely accepted criticisms of
an editorial nature stemming from such sources, without digging into
the true facts for themselves.
reports of clinical trails alleging to disprove chelation therapy are
all so flawed in design that they offer no evidence at all.
Doctors, however, are usually too busy to read every word, and often
accept the misleading summaries and abstracts, without analyzing the
data for themselves. The bypass and cardiovascular drug industries
have been extremely well marketed—to the medical profession as well as
to the public.
EDTA EFFECT metal IN stents and joint replacements?
EDTA has no effect on intact metals used for implants in the body, or
anywhere else for that matter. EDTA binds only dissolved and
positively charged (oxidized) metal ions dissolved in solution. Stents
and joint replacement are made from alloys such as highly refined
stainless steel, vanadium alloys and titanium, that will not dissolve
in body fluids
DOES HEAVY METAL TOXICITY CAUSE
It is a myth that heavy metal toxicity is an
important cause of age-related diseases such as atherosclerosis and
heart disease. Dr. Cranton has tested hundreds chelation patients for
levels of toxic metal levels. Although small amounts are present in
virtually everyone, levels have only very rarely been found to be in
the toxic range. Although laboratories used by some chelation clinics
tend to exaggerate the toxic potential of such low levels,
still do not know how EDTA chelation therapy brings its benefits.
WHAT ELSE IS
INVOLVED IN A COMPLETE PROGRAM OF CHELATION?
Your lifestyle counts. Chelation therapy is only part of the curative
process. Improved nutrition and healthy lifestyle are absolutely
imperative for lasting benefit from chelation treatments. Chelation is
not in and of itself a "cure-all"—it reduces abnormal free radical
activity and removes unwanted and toxic metals, allowing normal
healing and control mechanisms to come in to play. It has many actions
in the body and we do not yet know what is the most important.
Healing is facilitated, allowing health to be restored with the help
of applied clinical nutrition, antioxidant supplementation and
improved lifestyle. A full program of chelation therapy involves all
of these factors. Chelation therapy is also compatible with other
forms of therapy, including bypass surgery if all else fails. If
cardiovascular drugs are needed, they can be taken with chelation with
In addition to receiving the recommended number of chelation
treatments, patients eager for long-term benefits should follow a
healthy lifestyle, take a spectrum of nutritional supplements, be
physically active and eliminate destructive lifestyle habits such as
tobacco and excessive alcohol.
Hyperbaric oxygen treatment (HBO) involves treatment of the entire
body in a small chamber totally immersed in 100 percent oxygen, at
pressures greater than the normal atmosphere. HBO stimulates new blood
flow, and keeps organs alive and functioning, even when they are
deprived of adequate blood flow. HBO also helps fight infection. HBO
is especially helpful in cases of gangrenous or pre-gangrenous feet,
to speed healing while the slower process of chelation has time to
work, and to restore brain function following a stroke. Many patients
receive hyperbaric oxygen treatments on the same day that they receive
chelation for the added benefits of the two types of therapy.
A scientifically balanced regimen of nutritional supplements
reinforces the body’s antioxidant defenses and should include vitamins
E, C, B1, B2 B3, B6, B12, PABA, beta carotene, and coenzyme Q10, and
others. A balanced program of mineral and trace element
supplementation should also include calcium, magnesium, zinc, copper,
selenium, manganese, vanadium, and chromium. Dr. Cranton's Prime
Nutrients™, the best high-potency
multiple vitamin, mineral, trace element formula, provides a balanced
foundation supplement, all in one bottle and at reasonable cost. Dr.
Cranton's AntioxPackets provide a much more complete regimen at
additional cost , and are especially indicated for symptomatic and
elderly patients. Chelation patients are routinely placed on the
AntioxPackets™, one twice daily with
meals. That is what Dr. Cranton and his family take.
It is important to eliminate the use of tobacco. This applies to
cigarettes, pipe tobacco, cigars, snuff or chewing tobacco. It has
been a consistent observation that patients who continued to use
tobacco following chelation will experience comparatively less
improvement and for a shorter time.
Relatively healthy adults are often able to tolerate the moderate use
of alcoholic beverages without generating more free radicals than they
can detoxify. Anyone who drinks alcoholic beverages excessively risks
harmful free radical damage. Victims of chronic degenerative diseases
should minimize the consumption of alcohol.
Finally, physical exercise is very helpful. Even a brisk 30-minute
walk several times per week will help to maintain the health benefits
and improved circulation resulting from chelation therapy. Lactate
normally builds up in tissues during aerobic exercise, and lactate is
a natural chelator produced within the body. Which brings us to the
IS CHELATION THERAPY FOR YOU?
Only you can make that decision!
Chances are, your doctor won’t help you decide. Patients who choose
chelation therapy often do so against the advice of their personal
physicians or cardiologists. Many have already been advised to undergo
vascular surgery. Occasionally, a patient never hears about chelation
therapy until he or she is hospitalized and a friend or relative begs
him or her to look into this non-invasive therapy before proceeding to
surgery. In an impressively large number of instances, a new patient
comes for chelation on the recommendation of someone who has been
successfully chelated. Many patients have benefited even after one or
more failed bypasses.
You are encouraged to communicate with someone who’s shared your
dilemma, someone who can tell you about his or her own experience with
chelation therapy. Feel free to contact others with problems similar
to yours who have chosen chelation therapy. Most patients who have
been helped will be happy to give you their side of the story.